Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

70
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
70
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved Extracellular Level of L-Asparaginase in Shaken Cultures of Escherichia coli ATCC 11,303 Using a Statistical Design Approach.

Applied biochemistry and biotechnology·2026
Same author

Enhanced anti-EpCAM ScFv production and reduced acetate overflow in a BW25113-derived E. coli strain with ArcA and Pka deletions.

Microbial cell factories·2025
Same author

CRISPR-based gene editing in plants: Focus on reagents and their delivery tools.

BioImpacts : BI·2025
Same author

Optimizing recombinant antibody fragment production: A comparison of artificial intelligence and statistical modeling.

Biotechnology and applied biochemistry·2024
Same author

Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology.

Folia microbiologica·2024
Same author

Evaluation of Antioxidant and Antibacterial Effects of Lyophilized Cell-Free Probiotic Supernatants of Three <i>Lactobacillus</i> spp. and Their Cytocompatibility Against Periodontal Ligament Stem Cells.

Iranian journal of pharmaceutical research : IJPR·2023

Related Experiment Video

Updated: May 7, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

6.7K

Optimizing Gene Sources for L-asparaginase Production: A Comparative Review.

Vida Ebrahimi1, Atieh Hashemi2

  • 1Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Valiasr-Niayesh Junction, Vali-E-Asr Ave, Tehran, 19968-35113, Iran.

Current Microbiology
|July 11, 2025
PubMed
Summary

This review assesses L-asparaginase gene sources for cancer therapy and food safety. Application-driven gene selection optimizes enzyme performance, leading to improved therapeutic and food production outcomes.

More Related Videos

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
11:51

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence

Published on: April 27, 2018

12.0K
Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers
10:41

Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers

Published on: June 24, 2019

8.5K

Related Experiment Videos

Last Updated: May 7, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

6.7K
Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
11:51

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence

Published on: April 27, 2018

12.0K
Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers
10:41

Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers

Published on: June 24, 2019

8.5K

Area of Science:

  • Biochemistry
  • Biotechnology
  • Enzyme Engineering

Background:

  • L-asparaginase is crucial for treating acute lymphoblastic leukemia by depleting L-asparagine.
  • The enzyme also reduces acrylamide formation in high-heat processed starchy foods, enhancing food safety.
  • Enzyme performance, stability, immunogenicity, and production feasibility are significantly influenced by gene source.

Purpose of the Study:

  • To systematically review and evaluate L-asparaginase gene sources.
  • To assess the suitability of different gene sources for specific applications, including cancer therapy, food safety, and biosensing.
  • To highlight the benefits of application-driven gene sourcing for developing improved L-asparaginase variants.

Main Methods:

  • Comprehensive literature search across major biomedical databases.
  • Systematic assessment of L-asparaginase gene sources based on application-specific criteria.
  • Comparative analysis of enzyme properties derived from various gene origins.

Main Results:

  • Identified key L-asparaginase gene sources and their characteristics.
  • Demonstrated correlation between gene source and enzyme efficacy, stability, and immunogenicity.
  • Highlighted specific gene sources optimal for therapeutic versus food industry applications.

Conclusions:

  • Application-driven gene sourcing is essential for optimizing L-asparaginase.
  • This approach can lead to safer, more effective, and economically viable enzyme variants.
  • Provides insights for future advancements in enzyme design and deployment for clinical and industrial use.